IP Library Granted Patent US 9,977,017
Granted Patent B2
US 9,977,017 · App. 15/285,200 · Granted May 22, 2018

Apparatus for screening cells

Inventors: Aishun Jin (Toyama, JP); Hiroyuki Kishi (Toyama, JP); Atsushi Muraguchi (Toyama, JP); Tsutomu Obata (Takaoka, JP)
Assignees: TOYAMA PREFECTURE; VALNEVA
G01N33/54366G01N33/5047G01N33/566G01N33/6863G01N2333/52G01N2333/715
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,977,017
App. No.
15/285,200
Granted
May 22, 2018
Kind
B2
Abstract

Provided are a method and means permitting the simultaneous measurement of the reactive properties of more than 10,000 of antigen-stimulated lymphocytes being held on a chip and the separate determination of the states of individual cells. A microwell array comprises multiple wells and a coating layer on one of the principal surfaces of a base member, the wells being of a size permitting the entry of only a single cell into each well. A coating layer of a substance capable of binding to a substance produced by the cells contained in the wells is present on the principal surface around the wells. A method of screening for a target cell, comprises: causing specimen cells and a cell culture broth to be contained in the wells of the above microwell array; immersing the coating layer and the wells in the culture broth and culturing the cells in a state permitting the diffusion of substances in the culture broth from the wells into the coating layer; feeding a label substance binding specifically to a substance produced by a target cell present among the specimen cells onto the coating layer; and detecting the substance produced by the target cell that has bound to the substance in the coating layer by the label substance to specify the target cell.

Claims (11)

1. A microwell array, comprising multiple wells on a principal surface of a base member, the wells being of a size permitting the entry of only a single cell into each well,

wherein the microwell array is characterized by having a coating layer of a substance capable of binding to at least part of a binding substance produced by at least a portion of the cells contained in the well is present on said principal surface only around the wells, and

wherein at least a portion of the principal surface on which a coating layer of the binding substance is not present is coated with a blocking agent.

2. The microwell array according to claim 1 , wherein at least a portion of the cells contained in the wells are immunoglobulin-producing cells or cytokine-producing cells.

3. The microwell array according to claim 1 , wherein at least a portion of the cells contained in the wells are immunoglobulin-producing cells, and the binding substance is an anti-immunoglobulin antibody or an antigen.

4. The microwell array according to claim 3 , wherein the detection of the presence or absence of the binding is conducted using an antigen or an antibody to the immunoglobulin that is produced.

5. The microwell array according to claim 1 , wherein at least a portion of the cells contained in the wells are cytokine-producing cells, and the binding substance is an anti-cytokine antibody or a cytokine receptor.

6. The microwell array according to claim 5 , wherein the detection of the presence or absence of the binding is conducted using a cytokine receptor or an antibody to the cytokine produced.

7. The microwell array according to claim 2 , wherein the immunoglobulin-producing cells and the cytokine-producing cells are primary lymphocytes or hybridomas.

8. The microwell array according to claim 1 , wherein the base member is plate-shaped.

9. The microwell array according to claim 1 , wherein the diameter of the microwell is within a range of 0.5 to 2-fold the diameter of the cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2020
From: VALNEVA
To: BLINK BIOMEDICAL SAS
Reel/Frame 052830/0316 →
Priority Claims (1)
JP 2007-201493 · Aug 2, 2007 · national
Continuity (2)
Division 12671690
Related Publication 20170023562A1 · Jan 26, 2017